Colombia Awards First MMJ License to Canadian Company

a word from our sponsors:

advertisement

advertise here

Colombia has awarded its first medical marijuana business license to a Canada-based company, PharmaCielo Ltd. The company’s production duties will fall to PharmaCielo Colombia Holdings, a subsidiary of the Canadian company located in Rionegro, The City Paper reported last week.

For decades, Colombia played an infamous role in the illegal international drug trade. Today, the government pledges that it is committed against illegal drugs, and has approached the legality of medical cannabis cautiously.

In a press conference about the licensing, Colombia’s health minister Alejandro Gaviria Uribe said, “Colombia may be the winner of this emerging market of medicinal marijuana. This will result in more jobs in our country and greater prosperity for the communities and municipalities where this industry is situated.” Gaviria said to expect several more producers to be licensed in the coming weeks.

The administration of President Juan Manuel Santos sees the emerging industry as an opportunity for growth and a means to diversify the country’s economy away from oil and coal.

PharmaCielo now must apply for a cultivation license with the National Council on Narcotics, but the company is “one step closer to becoming a fully integrated licensed grower and manufacturer of cannabis oil extracts,” according to a press release issued by Pharma Cielo.

However, not all are pleased that the country’s first marijuana license was awarded to a company from Canada instead of a Colombia-owned enterprise. Jorge Iván Ospina, Colombian Senator and a member of the Partido Verde (Green Party), has since released a video of himself — surrounded by a sea of maturing cannabis plants — speaking out against the government’s decision not to turn the controversial crop back over to Colombia’s “indigenous and peasant communities.

End


Google May Be Considering the Cannabis Industry

a word from our sponsors:

advertisement

advertise here

Google — the major online search engine, advertising platform, and creator of the Android mobile operating system — may be eyeing ways to involve itself with the cannabis industry, according to a report by Marijuana Business Daily‘s Omar Sacirbey.

Google recently reached out to LivWell, a Colorado-based medical and recreational cannabis enterprise currently operating 14 dispensaries around the state, to see how it could get involved. The contact was discussed by LivWell CEO John Lord at an event for Rep. Jared Polis (D-CO), a long-time supporter of legal cannabis. Lord said that Google contacted him shortly following last month’s major partnership announcement between cannabis software company KIND Financial and Microsoft. The event was hosted by Dixie, an infused edibles producer.

The inquiry was confirmed by LivWell spokesman Matthew Givner in an email to Marijuana Business Daily, who said that the tech giant was interested in learning “about the industry’s needs and how Google could potentially work with us to address them. Beyond that, there has been no communication.”

It’s unclear why Google contacted LivWell specifically and whether or not Google has contacted other cannabis companies. In either case, it’s likely the first time a major U.S. corporation has expressed interest in working with companies directly involved in the production and distribution of cannabis, which remains a federally illegal substance.

End


Uruguay Pharmacies Hesitant About Selling Legal Marijuana

a word from our sponsors:

advertisement

advertise here

The New York Times reports that many pharmacy operators in Uruguay are hesitant about carrying marijuana at their shops due to fears about the safety of their employees and security of their businesses. So far just 50 of the country’s 1,200 pharmacies have registered with the government to sell legal cannabis.

Uruguay legalized the cultivation and sale of cannabis in 2013 in an effort to combat homicide and crime rates associated with drug trafficking. Two companies, International Cannabis Corp and SIMbiosys, harvested the first legal crops in the country last month.

Under the plan, marijuana prices are set at $1.20 per gram, and Uruguayans can buy up to 40 grams per month. The law allows registered individuals and cannabis clubs to grow up to 99 plants each. However some pharmacists — tabbed by the government to sell the drug — said in addition to the potential security issues, paperwork, cost increases, and customer opposition forced them to decline to participate in the program.

“My customers generally don’t agree with the plan,” Isabel Regent, head of the Association of Interior Pharmacies said in the report. “Besides the fear of robberies, enrolling in the system means a hike in costs and having to be up to date with all the paperwork demanded by the health ministry, and not all pharmacies are in a condition to do this.”

According to Gonzalo Miranda, a spokesman for the Uruguayan Chamber of Pharmacies, one union leader told government officials that some pharmacists have already been threatened by marijuana dealers who operate in the neighborhoods where the pharmacies are located.

Fernando Gil, a spokesperson for the Interior Ministry, said no such reports had been filed to police.

One pharmacist, unnamed in the report due to his customers’ negative opinion of the plan, said he signed up but is not sure he will actually sell the drug.

“I’m missing a lot of information,” the pharmacist said. “They haven’t explained anything to us about the information program that will be used or how the drug will be sold or how profitable it will be.”

Marijuana is expected to be for sale to Uruguayan residents 18 and older later this month.

End


Colorado Teens Using Less Cannabis, Facing Heavier Enforcement

a word from our sponsors:

advertisement

advertise here

Teenage cannabis use has gone down in Colorado in the years since voters enacted an amendment to legalize recreational marijuana — according to the Healthy Kids Colorado Survey, a compilation of data collected from Colorado students and published some weeks ago  — and yet, teenagers are finding themselves a more likely target for punitive drug policies.

The Healthy Kids Colorado Survey found that cannabis use among teenagers has remained more or less flat in recent years, with negligible differences between 2016, 2015, and 2013. New data shows that the number of teens who had used marijuana one or more times in their life decreased five points from 2009 to 2015, from 43 to 38 percent.

With adult use sanctioned under state law, however, marijuana enforcement has turned to the population that still faces criminal penalties for the possession or use of cannabis. The Drug Policy Alliance’s Amanda Bent noted in a recent report for Alternet that, “there were more than 400 expulsions and over 4,500 suspensions related to drug violations in the 2014-2015 school year despite efforts to curtail ‘zero tolerance’ policies recognized by the legislature in 2012.”

The punitive policies have also been shown to unfairly affect young people of color: despite similar rates of cannabis use, cannabis-related arrest rates among white Colorado youth decreased 8 percent from 2012-2014 while they increased by almost 60 percent for young people of color during the same time period.

Though fewer teenagers in Colorado admit to believing that cannabis use is a dangerous habit, perspectives on the dangers of other banned drugs such as alcohol or tobacco have remained the same since legalization.

Colorado legalized cannabis for recreational purposes in 2012. Some half-dozen additional states, including California, are expected to hold votes toward the reforming of their marijuana laws this November.

End


Report: Hawaii Dispensaries Could Earn $80.5 Million in Revenue by 2018

a word from our sponsors:

advertisement

advertise here

Hawaii’s medical cannabis dispensaries could earn between $12 million and $28 million during their first operating years, according to the Hawai’i Dispensary Alliance’s 2016 Industry Forecast. The group forecasts the industry could see revenues up to $80.5 million by 2018.

The predictions in the report are based on patient rosters growing from the more than 14,000 currently enrolled in the program to between 30,000 and 40,000 over the next two years. The report indicates that if the island state allows out-of-state patients access to medical cannabis, the program could generate an additional $9.6 million to $57.9 million in revenue.

“Hawai’i has the momentum right now to develop, grow, and evolve,” Christopher Garth, executive director of the alliance, said in the report. “The Hawai’i Dispensary Alliance believes that the best way forward is through the creation of a dynamic, creative, regenerative, local, world-class medical marijuana economy here in Hawai’i.”

The figures in the report are based on national medical cannabis prices and how much patients could spend at dispensaries. The alliance anticipates patients will spend between $100 and $200 per month, or $1,200 and $3,600 a year. On average, patients nationwide spend $72 per transaction at dispensaries. Under the law, patients can purchase up to one-half pound of marijuana a month, which would equal more than $2,000 in revenue, but Garth says patients buying the maximum is “unlikely.”

“And the dispensaries will not be the only ones to benefit from the growth of this industry,” Garth said in the report. “For every $1 spent in dispensaries, states with established medical marijuana industries report that $3 of additional economic value is injected into the economy at the local level.”

In April, Hawaii’s four member panel awarded eight medical marijuana licenses, allowing the approved companies to start selling cannabis as soon as July 15.     

End


Cannabis Quality Strategies & Solutions Summit in Los Angeles, July 19-21

a word from our sponsors:

advertisement

advertise here

The Cannabis Quality Strategies & Solutions Summit, coming to Los Angeles this July 19-21, will draw cannabis professionals and enthusiasts from around the country for a three-day conference to examine, explore, and celebrate the cannabis industry.

Cannabis Quality — hosted by nationally renowned business event producer Infocast — promises an industry perspective unique from other cannabis conferences by emphasizing the importance of first-movers, industry experts, and policymakers.

Speakers

Healthy relationships between entrepreneurs, policymakers and state-employed regulators are especially helpful when building a successful marijuana enterprise. Therefore, Cannabis Quality is bringing regulators from five western states that are leading the charge in cannabis normalization:

  • Fiona Ma, a CPA on the California State Board of Equalization;
  • Ken Groggel of the New Mexico Department of Health;
  • Heather Krug, MS with the Colorado Department of Health;
  • Shannon Swantek of the Oregon Health Authority; and
  • Kristi Weeks, JD with the Washington Department of Health.

Cannabis Quality is also bringing a host of esteemed experts, professionals, and researchers to share success stories, advice, and answer questions about all things cannabis.

Leading cannabis researchers who will be speaking at the Cannabis Quality summit include Ethan Russo, PhD, who is often considered to be at the forefront of cannabis terpene and endocannabinoid research; and Mowgli Holmes, PhD, who has been working with a team to create a three dimensional map of the entire cannabis genome.

Famed medical cannabis researcher Sue Sisley, MD — who has advocated heavily with state legislatures in the past to approve studies on cannabis treatment for veterans with PTSD — will also be sharing her knowledge and advocacy experiences at the summit.

Josh Eades, PhD and Vice President Chief Science Officer for Tilray, will be speaking as a representative for one of Canada’s largest and most successful medical cannabis producers.

Other notable individuals who will be featured at the summit include:

“We made an effort to go beyond the regional and partisan bias of many cannabis events,” said Jimmy Ma, Marketing Manager for Infocast. “We have state regulators from five different western states, we have representatives of different trade groups and nonprofits that have strong differences as to how legislation and regulation should proceed.”

“We provide a neutral platform, and we are experts at organizing intimate, ‘decision-maker’ events that bridge technical, policy and business needs,” said Ma.

Venue

The Cannabis Quality Strategies & Solutions Summit will be held on July 19-21 at the Millennium Biltmore Hotel Los Angeles, located at 506 S. Grand Ave.

Event attendees are offered a room rate of $169 at the hotel, which is famous for its 1920’s themed decor.

Tickets & Registration

Tickets to the Cannabis Quality summit are available online, though early bird price opportunities have already passed.

Standard tickets to the three-day event cost $1,295. However, there is a special ticket offering for cannabis operators (labs, growers, processors, co-ops, startups, and edibles manufacturers) who earn less than $1 million in annual revenue, as well as for individuals representing the government, a non-profit organization, or research institution — in these instances, tickets cost $795 for the full three days.

Register now at Canna-Quality.com.

Infocast is planning to return with another Cannabis Quality event in 2017, and has potential plans for two other MJ-focused events: one focused on investment, the other on cannabis scientific research.

End


Colorado Health Department Accepting Cannabis Research Grant Applications

a word from our sponsors:

advertisement

advertise here

Colorado’s Department of Public Health and Environment yesterday began accepting grant applications yesterday for the Retail Marijuana Health Monitoring Program, the Denver Post reports. The $2.4 million in grants will be used for post-legalization cannabis health effect studies, and will be awarded to researchers who have “a demonstrated record of successful grant-funded research or data analysis.”

Historically, similar grants have been presented to researchers connected to hospitals or universitiesFor-profit companies can apply for the new round of grants if they partner with a non-profit entity when applying. Governmental agencies can also apply for consideration.

According to the official request for applications released by the department, two types of grants are available; $300,000 per-year full research grants and $100,000 per-year pilot grants. Full research funding grants will pay up to three years and are intended for multi-year projects that “involve extensive primary data collection using observational study designs.” Pilot grants will pay up to two-years of funding and are intended for shorter term projects that “can provide important public health data.”

The department is specifically interested in studies concerning the safety and effects of marijuana use on “vulnerable populations,” such as pregnant or breastfeeding women, and the health effects from accidental marijuana ingestion; and health outcome comparisons between heavy and occasional marijuana users, however human clinical trials will not be accepted for consideration.

Capital construction, lobbying, cell phone and building renovation requests are not permitted under the grants, which were approved by the legislature last April. Preliminary applications are due by June 22, with an anticipated award date of Mar. 1, 2017.

Ultimately, grant research can lead to the establishing of new business infrastructure and an uptick in investments.

End


Washington LCB Adds New Disallowed Pesticide Products

a word from our sponsors:

advertisement

advertise here

Residues from one or more undisclosed pesticide ingredients have been discovered in fifteen different growing aid products common to the Washington cannabis industry, the Washington Liquor and Cannabis Board announced yesterday afternoon in an email to the LCB Marijuana listserv.

Many of these products contain pesticide ingredients that are not allowed in legal marijuana crops, and could cause products to fail the Washington State Department of Health’s pesticide testing requirements for cannabis products sold in Washington. In some cases, the residues could even lead to the confiscation and destruction of crops and products made from contaminated plants, the LCB warned.

The following grow aids — organized by type of product — are no longer allowed in the Washington cannabis industry:

Pesticides:

  • Safergro Mildew Cure for Powdery Mildew Control, WA Reg. No. 68573-08004
  • SNS 217C All Natural Spider Mite Control Concentrate, WA Reg. No. 998660-10002

Fertilizers:

  • Humboldt Roots 0-0.25-0.25, WA Reg. No. 1916-0028
  • Olivia’s Cloning Gel .08-.15-.09, WA Reg. No. 1181-0002
  • Optic Foliar AT-AK 0.06-0-0.15, WA Reg. No. 2097-0007
  • Optic Foliar Overgrow 0.8-0.16-3.2, WA Reg. No. 2097-0005
  • Rock Resinator Heavy Yields 0-7-8, WA Reg. No. 2422-0006
  • Root 66 1-1-1, WA Reg. No. 1707-0014
  • The Hammer 10-25-15, WA Reg. No. 1827-0015

Unregistered Products:

  • Frost Protection Plus, unregistered product
  • NPK Mighty Wash, unregistered product
  • OG Rapid Flower + Hardener, unregistered fertilizer product
  • Optic Foliar Switch 0-0.02-2, unregistered fertilizer product
  • Pyyro K 0-3-7, unregistered fertilizer product
  • Vita Grow Thunder Boom, unregistered fertilizer product

The LCB requires licensed cannabis producers to discontinue use of these products, remove them from the licensed premises, and advise all processors that have purchased cannabis with these products that their purchase may have been exposed to an undisclosed pesticide.

Licensed cannabis processors are required to post a notice about the possible use of undisclosed pesticides to any retailers carrying merchandise that may have been treated with the above products. In turn, retailers must post the note provided by the processor in a conspicuous location on the retailer’s licensed premises, for the consumers’ benefit.

End


Seattle Licensing Snafu Sparks Lawsuit Against LCB

a word from our sponsors:

advertisement

advertise here

The curtain is closing on medical cannabis in Washington, but Seattle-based dispensary owner John Davis is not giving up the fight to save his business.

Davis is appearing in court today to represent his business, the Northwest Patient Resource Center, and the plight of several other Seattle-based dispensaries, in a lawsuit against the Washington State Liquor and Cannabis Board. The suit accuses the agency of neglecting its duties and implementing an unfair and sloppy transition process away from the state’s heritage medical marijuana industry.

Though he was among the first to submit his application last October to be one of Seattle’s final cannabis dispensary licensees, “Somehow my information got put in wrong, and they weren’t sending me the emails,” Davis said.

Weeks passed, and when he didn’t received word about his application status, Davis began making inquiries with the Liquor and Cannabis Board. “At that time, they were saying, ‘Oh don’t worry about it … it takes some time, we’re all busy, we’ll get to you, don’t worry.’ Finally, I called up [LCB Director] Rick Garza. He said, ‘Let me check into it,’ and he called me the next day.”

Davis met with Garza and an investigator, and they revealed that his email address had entered their system incorrectly, and all of the information pertaining to his licensing process had instead been sent to one of his competitors. At that point, they shuffled his case through several different investigators to hopefully find a solution to the problem. However, by the time the mistake was rectified it was too late — the 21 additional licenses that had been allotted to Seattle under SB 5052 had been snatched up, and mostly by newcomers to the industry.

“You might want to move your proposed location,” an LCB-appointed investigator told Davis at the time.

“I don’t have a proposed location, I have a location,” Davis replied. “I have an operating business that employs people.”

In a phone interview, Davis told Ganjapreneur that at first he was optimistic about his chances of retaining his Seattle-based dispensary:

“The thing was supposed to be a competitive, merit-based application process. Pitch competing applications against each other based on merit? I’m like, ‘Hey that’s fine. I will pit my merit up against anyone else’s.'”

But that’s simply not how things went down.

Knowing it was his only chance at recourse, Davis filed suit in January. “The Liquor and Cannabis Board acted contrary to the plain language and to the intent of the law, and did not move over medical operations,” Davis said. “That was the mandate given to them by the legislature, but they did not care about moving over medical. They didn’t care about medical at all.”

Unlicensed medical cannabis operations will be fully criminalized starting tomorrow, July 1, despite announcements from the state that the government-managed registry of medical cannabis patients may not be ready, meaning patients in need will not have adequate access to their medicine.

A protest is taking place in downtown Seattle this afternoon against the damages caused by the merging of the two markets.

End


Canadian Feds Announce Cannabis Legalization Task Force

a word from our sponsors:

advertisement

advertise here

A nine-person task force will advise the Canadian government on marijuana legalization, according to a CBC report. The task force will be chaired by former Deputy Prime Minister Anne McLellan, who also served as a health and justice minister under Paul Martin.

During a press conference today announcing the move, Justice Minister Judy Wilson-Raybould said the task force will assist the Liberal government in designing legalization framework
“that will include a new system of strict marijuana sales and distribution.”

The government plans to introduce the legislation by spring of 2017.

The announcement comes barely a month after “Operation Claudia” was executed by law enforcement officials in Toronto. In the raid, police executed 43 search warrants at unlawful dispensaries resulting in 186 controlled substance charges. Another 79 charges were levied by Municipal Licensing and Standards officers for zoning and food permit violations.

“Production and possession of marijuana are illegal unless it has been authorized for medical purposes,” Wilson-Raybould said during the press conference, adding that police would continue enforcing current statutes until the new laws are passed.

New Democrat party leaders have been advocating for the Liberals to decriminalize simple possession of cannabis for personal use. New Democrat MP Guy Caron said he was “extremely disappointed” that issue is on hold until the new regime is determined and implemented.        

End


Aeron Sullivan: Creating a Wholesale Cannabis Marketplace

a word from our sponsors:

advertisement

advertise here

Aeron Sullivan is the founder of Tradiv, an online marketplace for wholesale licensed cannabis in Colorado. Tradiv has been recognized as an innovator in the cannabis industry, changing the way that cannabis commerce happens at this pivotal moment where a traditionally opaque and informal market has been pushed into the realm of transparency and formality. Our host Shango Los recently met with Aeron to discuss the evolution of his company and business model. Listen to the podcast below, or scroll down for the transcript!

Subscribe to the Ganjapreneur podcast on iTunes, Stitcher, SoundCloud or Google Play.


Listen to the podcast:


Read the transcript:

Shango Los: Hi there and welcome to the Ganjapreneur.com podcast. I’m your host Shango Los. The Ganjapreneur.com podcast gives us an opportunity to speak directly to entrepreneurs Cannabis growers, product developers, and cannabis medicine researchers all focus on making the most of cannabis normalization. As your host, I do my best to bring you original cannabis industry ideas that will ignite your own entrepreneurial spark and give you actionable information to improve your business strategy and improve your health and the health of cannabis patients everywhere.

Today my guest is Aeron Sullivan. Aeron Sullivan is founder and chairman of Tradiv, an online marketplace for wholesale licensed cannabis in Colorado. Today, we’re going to talk about the Tradiv business model and the country’s evolving cannabis sales channels. Welcome to the show Aeron.

Aeron Sullivan: Hey, thanks for having me Shango.

Shango Los: Aeron, let’s start at the very top. Let’s give folks a general outline of the service you provide to give them a better context for the rest of our conversation.

Aeron Sullivan: Absolutely. One of the ways that we use a comparison to help people understand what we do is we use Amazon. Now, Amazon is a business to consumer distributor. They both help process, and ship, and manage orders for millions of consumers all around the world. Now the businesses that sell those products are not owned by Amazon. Many of them are independent businesses that are utilizing the Amazon platform to sell and distribute those products.

Similarly, we use a platform that helps concentrate producers, edible manufacturers, and cultivators to sell their products directly to licensed retailers and dispensaries in the markets that we serve, all using a technology platform that helps unify it in the center of that ecosystem.

Shango Los: I know there’s a certain bar to entry because everybody would want to participate and just to be clear for the listeners in states other than Colorado. At this point, you really need to be both in Colorado and have a license by the state correct?

Aeron Sullivan: That’s correct. Actually, as of right now we are doing our early on-boarding for beta customers in Oregon and California depending on where they are in that market or their states. I would encourage anybody in the California, Oregon, or Colorado markets to reach out to us but only those in the Colorado market we be able to serve really from the point that they sign up. The rest will have a little bit of a wait.

Shango Los: That makes a lot of sense. I expect that with how huge the California market is going to be, getting started early is to everybody’s advantage because everybody is going to suddenly want to get involved out once. If you can get involved with your company, get your things all setup and then just kind of hang out and wait for the rules making to happen, that’s probably going to be to everybody’s advantage.

Aeron Sullivan: Definitely, I think the thing to remember in California specifically is that MRSA was passed last October and signed by Governor Jerry Brown signed. That’s taking effect in January of 2018, however we’re all going through the rules making process right now. The State of California, the governor’s office is pretty clearly communicated to Cannabis businesses that they can operate on the old collective model until January 2018. At which point there is going to hard switch to a more commercialized, tracked system.

Again, that doesn’t take effect until 2018. Those are the one to get involved early and have a really good opportunity to do that now. It’s just the patch work of legislation and rules across the different municipalities and it need to be looked at closely make sure that you’re not breaking law frankly without really even knowing it.

Shango Los: Let’s bring our attention back to the marketplace. I really enjoyed the demo from Willy the other day, walking me through it. It was seeing a technology from the future. College me would have been like “Oh my God, I can’t believe this exist.” It is a wholesale market place online. What you’re doing is connecting buyers and sellers. Do you find that having the buyers and sellers all in one place has caused the prices to settle in to a small range or are the prices still very variable?

Aeron Sullivan: What we find is that the market as a whole is not really much, it’s not more volatile or less volatile with us in place. However, when calling or inquiring about prices from business to business you’re now getting less spread on those prices or less variance if you will. The average is still moving where the average moves, but I’d say you have a tighter grouping towards that center, mean, or average than you would otherwise without us.

Shango Los: Also with that said, one of the things that I found interesting is that you still have premium level flower that is still pulling in premium prices because maybe it’s organic, or veganic, or it’s made by a particular producer who’s got a great reputation and their wholesales for a premium price. It’s not like the marketplace is bringing everybody to the middle so much that you can’t be a premium processor with high end prices. I bet you, your customers really appreciate that?

Aeron Sullivan: Yeah. I would even dare to say that for a boutique and more specialized growers, they actually get more differentiation now because you have less price variability amongst the different cultivators. Everybody knows where their product falls, if you have really good organic greenhouse you might be getting a higher price point along with those that have really good indoor. Every vendor, every buyer is different. They have a different customer base, maybe their customer base likes organic, maybe their customer base really like strong THC, indoor hydroponic.

Both of those can be “quality premium products” that give you a higher price point above average. You have to be able to find those things, you have to find those distinguishing qualities to even make that decision. We’re making a lot easier for dispensaries and retailers to consume that information in a quick manner to make the purchasing decision.

Shango Los: Are you finding that there’s a particular section of the market that just doesn’t sell as well as the other? For example, do you find that “Yeah, there’s premium prices but that stuff doesn’t go as fast. Yeah, there’s low-end stuff but it doesn’t go as fast.” Is there a particular part of the market that is slower than the rest?

Aeron Sullivan: I can tell you there’s a particular part of the market that’s faster than the rest. That’s those with good quality product, selling them at reasonable prices that sells very quickly. If you’re trying to get a price that’s really outside of the quality of the product, you might get it but you’re going to wait a while. You’re going to have to be patient.

For those that produce I would say outdoor, there’s a big spread on outdoor. There are some that grow really exceptional outdoor but by in large it’s always sub-par compared to green house or in-door. They like to send that to manufacture. Manufacturing can find their $900 to $1100 popcorn buds, or premature buds, or even the shake and the byproduct that’s a good high quality. When it comes out the other side, they’re going to look like what they do if they got trimmed flower.

They’re paying a lot less for that and in the past, when you’re buying trim you don’t really know what you’re getting until it gets to your doorstep. We identify what’s the level of shake on it, is it sugar trim, and sun leaf is it all sugar? What’s the reputation on yield off of their trim, off their previous harvest? Did we have all that information? When a manufacturer is looking to make a purchase, this is a lot more certainty in what they’re buying than in the past.

I think across the spectrum. If you have something of quality, your buyers will all going to look different. Different shapes and sizes, but as long as its good quality, for whoever the eye of the beholder is and also price reasonably, it will move fast. If you’re trying to get too much for it’s going to take some time.

Shango Los: I can imagine that you’ve had a handful of experiences with producers where either A, they thought that their product should demand more on the market that it does. Also, the other side, people who they didn’t have as much faith in their product now suddenly they’re getting more for it. Because the markets got its own intelligence way beyond what the producer themself thinks.

Aeron Sullivan: It’s really true. I have an example is we just launched … We’re launching full quality assurance and quality control tasking here really soon but we launched the beta in Colorado just to refine the processes and make sure it work. We launched something very simple. It’s pesticide tested trim. Period. We went a little further than typical normally you have a lab assist, “Yeah, I tested it for pesticides.”

Everybody knows there’s been a lot of an apprehension on the market side to believe the results of those lab tests and to trust those recalls that come from the state. There’s a lot of animosity that’s been generated because of that sort of you versus us mentality with now the businesses in Colorado and the state who’s coming down hard on pesticide tests. We actually did proficiency testing with one of our labs. We got the state levels from the Department of Ag on the threshold for pesticide within the cannabis matrix.

Our director of quality assurance and control Jeanne Dugan did a great deal of work to put this very simple or one would think simple beta and test. That’s to ensure and guarantee that trending purchase by manufacturers does not have pesticide in it. We didn’t know how the market was going to react, that’s the first time that’s really been available and invalidated by a third party. We have dozens of manufacturers that now even in a short two weeks after launching that beta, will not buy trim that is not certified by us.

Clear market signal, that’s what people want. They want safety, they want risk mitigation, they want a third party making sure that these things are being done the right way which de-risks their business and they don’t frankly have to do it themselves.

Shango Los: That’s a really great way for the industry to stay ahead of the regulators too because if we are starting to come up with ideas like that, it takes the onus off the state or God help us the federal government to enforce that in their way. It lets us to choose how our industries going to be run ourselves instead of dragging our heels until they do it for us. We need to take short break right here, we’ll be right back. You are listening to the Ganjapreneur.com podcast.

Marketing and brand agencies can be really unhelpful sometimes. I mean you pay them and you have meetings but there doesn’t always seem to be real value created. They’re sure they may make you a logo or a website and you talk about the image your company want’s to project. That is not always reflected in the bottom line in the form of actual revenue. For a lot of startups everything is got to feed the bottom line just so they can survive.

That’s what Blunt Branding does, they feed your bottom line. Blunt is very different from other agencies because their principles Kirsten Nelson and Anthony Garcia are experts in psychological marketing. For example, they don’t just write copy for your website. They write copy that includes hooks and triggers for every Myers Briggs personality type. Most copywriters tend to write only for people who think like them. Blunt Branding does better than that.

They reach all your potential customers. In fact, if there’s a certain kind of customer that you don’t want, say argumentative folks, Blunt will write you copy that attracts everyone else but will tend to repel the kind of customer that gives you grief. I’m not kidding. This strategy is used by their attorney clients all the time. Your brand is much more than a logo. You see most customers wait for some company to wow them with something more than they came shopping for especially when there are so many options.

They’re looking for a brand to anticipate their questions or solve their problems or just make them feel seen, heard, and valued. I know that can sound corny but we all know that we buy from the companies we feel most engaged with, and Blunt Branding will get them climbing over your competitors to get to you. If you cannot risk business failure, you should be working with a marketing team who understands that their goal is not just to make you pretty but to directly increase your sale success too. Go to bluntbranding.com to find out more.

Welcome back, you are listening to the Ganjapreneur.com podcast. I am your host Shango Los. Our guest this week is Aeron Sullivan up Tradiv. Aeron before the break, we were talking about the new policies that you guys have implemented to pesticide test all of the trim that’s going through and you’re finding that the market is responding really strongly to that and switching to buying the stuff that has been tested. That is great for everybody across the board.

When I was receiving the demo of the platform, I noticed that some of the sellers didn’t have their certifications up, their potency testing and such. Do you find that, that is simply the producers, it’s their follow through getting it actually on to their listing, or that they aren’t having it tested, or that I guess it’s just one of those two. Why do you find that they’re not all there? I would think that, that would be kind of a universal thing?

Aeron Sullivan: Absolutely. Sometimes it depends on when the product was posted. If the products been up for week, then more than likely the lab test has been already uploaded. If they just posted the product, it might take a day or two, sometimes even three for the lab test to actually come back. What we’ll do is because delivery can take anywhere from two to three days then oftentimes there is a little bit of a wait where we actually have the opportunity to let them go get the test results, bring them back before the product is actually sold.

In any case, if a product is sold whether or not we have a posted lab result or not, the lab result will always be gathered and then provided to the dispensary that’s purchasing at the point of delivery to ensure that nothing ever gets delivered or purchased without certified lab results traveling with it. Now, that doesn’t necessarily mean that it’s tested for heavy metals, solvents, pathogens, potency, and pesticides that just means for that particular product it meets the state testing requirements whatever they may be for that particular product.

In the case of our trim, we’ve gone above and beyond the state required tests to ensure that it’s also tested for the 15 different pesticides that the State of Colorado currently recalls for.

Shango Los: I can imagine how we’d all like all of the products to be tested for pesticides, but that’s especially important in the trim market because we know that most of that stuff is going to be concentrated into oil which, if it’s got pesticides, means that the pesticides are going to be concentrated too. Man, I don’t want to be dabbing that stuff. Hell, I don’t even want to be eating that in an edible.

Aeron Sullivan: Absolutely. Frankly, Shango that’s why this is an easier problem than many people think. Trim comes from flower. Manufacturing products come from trim and flower, edibles come from trim and flower. Everything comes from trim and flower. If there was a requirement even during the growing process maybe at one or two stages then eventually it harvest to test just the full bulk plant for pesticides before it enters the rest of the supply chain from that cultivator.

You can stem pesticide adulteration, contamination across the entire market by simply testing the flower before it’s been completely cured, before it’s been completely dried, before it’s been trimmed, before it’s now in the supply chain and nobody knows what happened to it.

It grows from one place and you can test those for pesticides and literally, unless you’re worried about black market product moving it’s way into manufacturing facilities which frankly is a much larger issue than pesticide testing. Then you’re able to stand the flow of pesticides and nip that in the bud very early. That’s really what we’re looking to do in the new markets and and help Colorado get that point where there isn’t a product sold that could possibly have pesticides. It’s wonderful that we’re giving medicines and medications to small children with seizure disorders for the first time in their lives they can live a day without a seizure and actually start to grow as a human being.

We’re not doing them a service if that same medicine that’s providing them the first relieve in their short life that they’ve had, we’re also heavily dosing them with carcinogenic pesticides. It’s almost beyond me that we’re allowing that to happen. So far the state, most of the state governments I think Oregon might be one of the exceptions hasn’t been able to adequately attack this issue, so private enterprise is going to have to do it.

Shango Los: I can see how the trim that is in the market being used for this concentrates is going to be a higher quality because of your new policy. It also going back to the price of trim, I can imagine that the trim market is like insanely hot since it’s a precursor for pretty much all of the value added products. Yeah, of course the flower market is hot. This huge portion of the rest of the market are all of these edibles, and dabs, and RSO, and all of these other things that are all from trim. I can’t imagine that trim lasts very long in the marketplace before it’s picked up.

Aeron Sullivan: No, typically we have buyers for trim before it’s posted and tested. Yeah, we always have request for trim. I mean every once in a while something will sit on there for 24 to 48 hours but it’s pretty rare when trim is not purchased up right away. It’s because the manufacturer’s margins are most impacted by the oil and the cost of the goods of the actual THC going in the product. I mean in many cases they comprise 70% of the cost of good sold.

If you can create oil from product that you’re buying for $350 to $500 a pound and it has a yield that’s at least half of what full flower at 15 to 1800 would do. Then yeah, that’s a pretty good way to help have the margins and be more competitive.

Shango Los: I can imagine too that with the demand being that high, there are definitely days that low-end or unfinished flower gets sucked up by the trim people real fast.

Aeron Sullivan: There’s actually quite a few contract grows that produce what wouldn’t be shelf quality outdoor. It’s 16% THC, you don’t have to trim its whole plant. There’s definitely a full commodity market out there for manufacturing grade of cannabis, that’s already in production. I think as you see price compression on the flower side as supply increases overtime. You’ll probably see those trim prices come down and that commodity level flower probably moving down to the current trim price points.

Many products I think in the future is especially concentrates will probably be whole plant extracts because that’s what the markets going to demand because prices gone low enough on flower to be able to accommodate that sort of manufacturing method.

Shango Los: That’s really creating at a whole new tier of producer because historically in the US the really bad stuff was all being smuggled in from Mexico as brick weed. The stuff that was here or was coming in from Canada, British Columbia, it was all nice, kind nugs and that’s what everybody wanted to have is to sell things that were selling bag appeal. It takes a lot of extra effort and love to get stuff that looks that incredible.

Now, there’s a whole other tier I can imagine evolving of people who are like, “All right, we’re not going to use pesticides but we’re also not going to put in all the extra effort that makes it gorgeous because we’re just going to sell a hell of a lot of this in the manufacturing.”

Aeron Sullivan: Absolutely right. I’m glad you bring this up and so there’s a lot of people that have invested a lot into indoor grows or indoor warehouses. There are brands out there right now that are going to be built on indoor warehouse grows. Good high quality product, looks, has nice curve appeal, it’s coming out of this indoor grows. A lot of vertically integrated businesses in climates that aren’t conducive to outdoor greenhouse growing, have indoor grows.

Those indoor grows are going to help build those brands but for those entrepreneurs that are looking to get into the industry now that haven’t been building in Brandon, Colorado for three to four years and don’t already have an indoor grow, I would highly recommend, I would stress that anyone looking to move into cultivation now, invest in greenhouse. Because greenhouse technology is getting so good that people can produce flower that looks, feels, and tastes like indoor hydroponic.

They were able to do it in a greenhouse system at one-fourth or one-fifth the cost of good sold. We’re already seeing in Colorado, when you have a lot of businesses that are making money there’s a lot of less perceived risk in the market which causes those less bold and less risk averse entrepreneurs to enter the market. You have a huge flood right now in Colorado of new cultivators who see the money moving and want to get it and there’s less perceived risk and so they’re all coming in. We have massive price compression in Colorado right now.

I would dare to say 15% of the cultivation businesses and business in Colorado right now will not be in business this time next year. Because the price of flower sold has just come down to where that high price point that indoor used to get you isn’t being achieved but their cost of goods are very, very high. That movement to good premium greenhouse and I would say commodity level manufacturing quality outdoor is probably going to be the future of the market. It doesn’t mean those businesses are going all of a sudden go out of business in the next four years.

If you have an indoor grow, near Las Vegas it’s going to be tougher anyone to grow a good premium outdoor there because the climate isn’t conducive to it so they’ll make money. As the market matures, as competition increases, as the federal government might open up interstate commerce, that competition is going to get a lot stiffer. That price compression is going to get even worse and the price of that products going to come down.

The hay day of I can just start a cannabis business and make a ton of money is over. You have to pay attention to cash flows, you have to pay attention to cost of good sold because it’s not … It might be wild west market but it’s certainly not the green rush market that it was in say 2011, 2012. It comes in a way but there’s a lot of interest now.

Shango Los: Yeah absolutely. Heck, just wait until the wait happens when we start allowing international trade.

Aeron Sullivan: Absolutely.

Shango Los: My god. Your point is well made that it takes more than just opening a cannabis business to be in the game now and to be successful because of the price compression, you can’t just have skills on the cannabis side or on the business side.

It’s really time for people who have an understanding of both. When I first started in the industry, I was providing consulting to cannabis folks who were prohibition era growers who didn’t really have legal business experience. I was helping them make the transition and understand sale cycles and things like that. At the same time, there were people who owned a chain of dry cleaners and they wanted to sell their dry cleaners and put all their money in cannabis.

They didn’t know cannabis and so they needed somebody who spoke their language who could teach them cannabis. What you’re describing is the sustainable business in cannabis are going to be run by management who have got both sets of skills so that you can both create a good product and see opportunities but also do it in an efficient way so you can keep your prices low.

Aeron Sullivan: You hit it on the head. Most of the successful businesses, and listen, this is the cannabis industry. It’s been legally illegal for two decades so nothing should surprise us at this point. Most of the successful businesses that I interact with have somebody on the business side who knows how to execute on fundamentals. They come from a professional market where there was a tremendous amount of competition.

They know how to execute it on fundamentals. They know how to watch cash flows, they know how to finance, they know how to capitalize the company, they know how to hire employees correctly, they know how to make sure that they don’t make big, red line risk mistakes that being said. I know a bunch of those guys, a bunch of those women that grow subpar products and can’t sell it no matter how good their fundamentals are.

You have the best businesses, have the fundamentals person and they have somebody that came from the black market or maybe the gray market. Because they were the only ones that have been learning how to do product creation and innovation for the last two decades. You’re not going to learn that in a year. You really do, you have to have someone that knows how to grow a good quality product. We had people, they come to us all the time and say “Hey, I’m putting in 100,000 square foot grow. I’m putting in a 200,000 square foot grow.”

That sounds sexy, that sounds awesome, but managing grow of that size is incredibly challenging, especially for the master growers who have been growing on 5,000, 10,000, 15,000 square foot plots in Mendocino and in places in Humboldt. You have to find really talented master growers that have been doing this at scale for the last 10 years and bring them into a well capitalized organization buying a 100 or 200,000 square foot grow. There’s a lot of people that have been doing this for a long time. There’s not a lot of people that know how to manage a quality grow of 300,000 square feet at scale anywhere.

Shango Los: Yeah, there’s a lack of that talent.

Aeron Sullivan: Absolutely. You have these business people come in and want to scale. You have this really talented growers who know how to grow really quality weed in a basement, in a house, on a small plot in Northern California. You have to find a really talented black or gray market individual bringing to your company that you believe not only knows, it just doesn’t just check the black, oh you’ve grown weed before.

They might have grown crappy weed, you don’t know. Just because they’ve grown it in the black or gray market does not mean that it’s good. You’ve got to find an especially talented person that you believe can do that at scale while you execute on fundamentals. It’s very challenging.

Shango Los: I want to hit one more thread before we go to commercial and that is we’re talking about the kinds of customers that you have that are probably most likely to succeed. Going through your platform, I saw that the growers have to let you know if what their product looks like changes so that they can upgrade their photo. If they change something about a strain or a product, they have to make sure to update their listings.

You’ve got people who are helping them and advising them. I find it very interesting because a big part of what you do is not the technology alone of the platform that your developers are working on. You’ve got to have this big contingent that is customer service based to help your customers wrap their head around the product itself, the service itself, but then also to reach out to them so the growers look good enough on the site to actually make a sale. I bet you that’s a big educational sales process with them?

Aeron Sullivan: No, absolutely. I mean, this is something that I believe applies to all companies in this very new fast paced world that we find ourselves in. Something that Silicon Valley did a very poor job between 2000 and 2010 with the explosion of computing technology, explosion in commodification of server space is that there’s been a period of time. I’d say the evolution of business models industries wide that thought “Hey, computers can do so much for us, we’ll make them do all the perfunctory stuff for us and we’ll make a lot of money because our margins are 93 or 94%.

That’s all good until a business comes along that does all the automated stuff you do and then backs it up with really good people and really good services. We call it value added marketplaces or service, or value added services to a marketplace or platform. Every business, every single business in the entire world is a relationships based business backed up with technology not the other way around.

It’s taking us about a decade or a decade and a half especially on the Peninsula up where there’s a lot of innovation to learn that technology is here to make humans enabled to do better not to completely automate us out of the existence. Our sales reps and our account executives, 80% of their time they spend talking to a customer. 20% of the time they spend doing back office work. For most of our clients that we interface with, it’s the opposite. There’s been 80% of their time managing order to spend like this perfunctory, rudimentary tasks.

Then 20% of the times actually talking to the customer because interaction with the customer is not the same as service to the customer. If I call to say, “Hey, how many pounds of this that you have? Does this order look good? Did I give you enough? Okay, it’s going to be there at 3 on Thursday, thanks so much for ordering.” That’s a perfunctory rudimentary interaction, that can be done digitally but when they call and take that same five minutes and say, “Hey, how did that order go? Hey, I heard you just had a baby. Congratulations. How are things going at work? Is there anything I can do to help make your wholesale management easier the next couple of weeks as you come back into work?”

Whatever it maybe, that’s real customer service and that’s why we have technology. It’s not because technology is the answer. It’s just an enabler.

Shango Los: That is incredibly well said Aeron. Hey, we need to take another short break. We’ll be right back. You are listening to the ganjapreneur.com podcast.

The Ganjapreneur podcast is listened to by tens of thousands of cannabis entrepreneurs and enthusiasts every single week. These folks are most likely your target customers and we like to introduce you to each other. Our down to earth and information rich commercial breaks can deliver your message to the cannabis business community and others who just find relief in getting high.

If you want to reach out and connect with our audience in the most personal way that we can offer, go ahead and drop us an email at grow@ganjapreneur.com and we can talk about you becoming a commercial sponsor of the podcast. Thanks for listening and being part of the Ganjapreneur family, now back to the show.

Welcome back. You are listening to the Ganjapreneur.com podcast. I am your host Shango Los and our guest this week is Aeron Sullivan of Tradiv. Aeron, before the break we were talking about the last step of the process of getting the actual products to the retailer from the producer. I’m really curious because that could be a sticky wicket right? Do you actually handle the product yourself and make the deliveries or are you just setting the deal and then the producer is actually making the delivery to the retailer?

Aeron Sullivan: Yeah. There’s a little nuance to that answer. I mean the ones for short is it depends on the market and it depends on where you are geographically within that market. In Colorado, we’ve largely used courier. Great courier, green parcel service, they do a lot of good work for us in Colorado. Based on cost, they’ve actually stop servicing in couple of areas that we’ll be putting one truck in to help provide coverage for that area. That’s very much sort of a partnership logistics system that we have setup in Colorado.

In Oregon, we’re actually in discussions with two groups right now and whether or not we’re going to contract it out or if we’ll eventually have to put our own vehicles in. In California, in much the same way we have a series of vehicles that we put in and operate, and then work through a few partners with the other areas. We envisioned having most of logistics assets in-house or having one or two service level agreements with very qualified and reputable couriers that I don’t think we have yet to identify.

Where it could be green parcels service, it could be our partners in California. None of us have been in business long enough to find out who’s really going to push that customer service envelope the most. The reason we do that is just like Amazon, your user experiences everything from when you order to when you receive it in a day. When you’re happy to send it back because it’s not what you needed and they have an easy process that’s repeatable every single time. Our business is like that and so the logistics aspect, the actual delivery of the product, that’s part of the user experience.

We have to be able to control that user experience to give them the best experience or consistent experience every time. We hope to do that in the lesser capital-intensive nature that have new investment in your own logistic assets but sometimes that’s just not possible. It really depends on the state, the market, the geography. We use a combination of, but always sort to make sure that, that user experience is as best as it can be.

Shango Los: At that final point, if there is some dispute resolution needed, how does that play out? Say for example, if the delivery arrives and you guys have set up the deal and the flower isn’t up the quality of the pictures or there’s a quantity issue or something. What happens in that moment between the delivery driver and the receiving person that keeps everybody playing nice?

Aeron Sullivan: That’s a challenging area that I think even if you’re an individual business doing self distribution, you’re going to have to deal with those things. For us, we obviously are trying to scale and we’re also trying to make that user experience as easy as possible. Again, that actually comes down to geography depending on where you are. We have a different process. If we’re delivering to a remote area that we only get to once a week and they’re not happy with something, we’ll often times try to solve that there.

Meaning, maybe it’s just a cost adjustment and maybe there was a mistake with the order. Our delivery driver or courier will actually call the account executive who will call the seller and see if we can’t find a resolution at that particular moment. If the buyer doesn’t want to do that, if the buyer is just not happy, we have free return. It’s rejection at the door. They say, “I don’t want this one. We manifest it back.” The sellers already contract with us to receive that.

The whole buyers were more as a big barrier for businesses ordering online because they can’t see or taste it. In reality, our returns are actually quite low. We just have the policy of free returns, no questions asked, at the door you can return it. If you accept the product and find later that you don’t want it, we have a couple other procedures in place for that as well. It’s certainly our preference for them just to say, “Hey. This isn’t what I wanted.” No harm, no foul.

Shango Los: That sounds like a great way to go about it. I can imagine that because of your market share, you’re kind of influencing how businesses interact with each other. You’re helping create the social morays and the social contract if you will that’s happening between buyers and sellers.

Thinking about that while you were speaking, do you feel like you’ve gotten over the hump in Colorado yet where you got enough market share that you have started to become the default setting for people, where you don’t have to try so hard to sell anymore, and you have enough customers talking about how easy it is to work with the product that now people are just coming to you as the default setting? Have you reached that milestone yet?

Aeron Sullivan: Yeah. This is what I would say. There’s a number of clients that I actually want that do some level of self distribution on their own. The funny thing is that’s really because they had to. They’ve been in Colorado now for five years. There was nobody providing a distribution service. They had no choice but to buy their own trucks and to build their own distribution.

Many of those companies are actually using us for everything in their Oregon and California expansions because we have brand recognition and reputation with them. Many of those sort of self distribution companies are paying between 11 and 13% for their own self distribution if they’re doing it efficiently. We can do it for around 4, 5, or 6% and we collect the monetization in the in-between from much of those larger businesses that we have to provide a larger level of service for.

In Colorado, I’d say this. If your business or there is a business that doesn’t have their own efficient self distribution capability, we are the default. For a few of those businesses that might be below 3 million in annual recurring revenue but above a million in annual recurring revenue and have some self distribution, I would say by the end of the year we’ll likely have enough features and service sets to attract that second tier of businesses. Without being more overly verbose than I have been, in Colorado we’re over the hump from a competition perspective but we’re not over the hump from a sustainable, I guess comfortable market share perspective. If that adds up.

Shango Los: Yeah, I understand that. I had the opportunity to hear you speak when you and I were both speaking at the Green Flower Cannabis Entrepreneur Summit down in LA last month. I knew I wanted to have you on the show because listening to you speak specifically about channel distribution for cannabis, you had insider’s knowledge that I had not heard anywhere else which would make sense because you’re the first person to be doing this in the country.

I just liked listening. I became a fan real quick. I’m curious to know what do you feel is an insight that you’ve discovered being on the inside of this unique commercial cannabis space that you’re in that those of us who are not in your shoes could not know yet?

Aeron Sullivan: Man, no one’s going to like me when I tell them this.

Shango Los: Go ahead man, laid out for us.

Aeron Sullivan: This is really crappy for a lot of businesses because there’s a lot of small businesses that went through raids for 20 years, that pushed the envelope long enough and hard enough that other states were able to adopt legislation. Because the taboo nature of cannabis had been slowly chipped away for two decades starting with like these patients in San Francisco, in the early and mid-90’s. There’s been a lot of blood, sweat, and tears that have helped build this industry.

Unfortunately, a lot of those people that have helped build this industry, because market economics are so powerful, are likely going to find themselves either outside of the industry, or in a position within the industry that wasn’t as favorable and certainly not as profitable as it was in a gray market, and this is why.

This is going to go to manufacturing eventually. The ability to break down cannabinoids and terpenes in specific combinations and reformulate and compound them is likely going to be one of the largest areas of the industry, specifically for wellness and medical purposes. Unfortunately, only large pharmaceutical companies are likely going to have the money and the capital to learn how to break those down into all of their components and to re-culminate them. They might be making acquisitions of businesses like ebbu or LucidMood that have been able to do this in the past, but that’s where it’s going to go. It’s going to go to manufacturing because they can target specific needs and that medical market is going to be a very large market.

You don’t use market where they burn flower. Hey, yeah that’s likely going to be big too. The wellness and the medical market are way behind right now that they’re going to pull way ahead which means that you have to genetically modify the seed in order to propel certain cannabinoid production. Let’s say CBV, curves hunger, we really want high CBV plan production because we’re going to extract it. If I can make a plant with 5% CBV instead of .02%, I’m going to do that as a business owner. I’m going to hire a genetic company to build me a seed that does that.

Which means all of the intellectual property and the money-making capability is in the genetics and the bio design of the plants that are being grown. Then the rest of the values in manufacturing where they can breakdown this specific cannabinoids and terpenes. Many of those in between are going to find themselves in a commodity market much like any other agricultural, farming market. They don’t own the IP going into the ground because they’ve been hired to grow it by a manufacture who needs that particular cannabinoid and then the values are going to be created by the manufacturing company.

To be able to grow really high-profitable cannabis is going to be held by a very small percentage of the market. I’d say 15 to 20%. Much like boutique coffee, 18% or so. For many of those businesses, I feel really sorry because they helped build the industry and in that big fear that everybody has about big business coming in, they’re absolutely going to come in. The way that they come in is not going out and acquiring 15 grows. They go out and they acquire bio technology, allow them to modify the seed, and then manufacturing base that can break it down, and then they just contract pharma at low margins.

If you’re in the industry now, I would look very heavily at brand building. Because those brands are going to be the ones that after it goes commodity are able to sell into larger organizations that are trying to consolidate the market. You have to build your business for what is going to be desirable for an acquisition in the next three to five years, or build your business with all of those macro level economic powerhouses at play, so that in three to five years when you want to hold on to your company, not sell it, you’re in a position to be able to do that.

The market in the industry is going a direction that most of us can’t control. It’s not even anyone, any particular business doing it. It’s not … it’s not Procter and Gamble, it’s not Cisco. There’s not anyone particular company that’s causing the market to do this. It’s just economics and they’re not going to stop for anybody. We have to prepare for those or we’re going to find ourselves in a world of hurt in three to five years.

Shango Los: That’s a really sobering cautionary tail. Over the year that we’ve been on the … I was going to say on the air, but streaming. This is a common theme that we’ve heard from the scientists we’ve talked to, people who are in relationships with pharmaceuticals that the future of medical cannabis is patented genetics, people holding their IP, and genetic line insertion so that you can create a plant that is customized for a particular patient.

Now, the genetic modulation does not necessarily have to take place also in people who are burning flowers and they wanted to be organic and hybridized. It’s going to be different markets. The commoditization of medical and people using the oils that they’re going to custom blend, everyone seems to be agree that that’s the future.

That’s all the time we have for today Aeron. Thank you so much for being on the show and sharing the experience that you have gathered being a leader in Colorado, and getting ready to take your company national.

Aeron Sullivan: Thank you Shango. It was a pleasure being on and we’re not here to scare anybody. It’s just knowledge is power and arming people with information, even if it’s unsavoring information allows you to pivot your business model and prepare. I hope if anything we were able to both get people excited but also give them some good as you said sobering and cautionary tales on how to ensure that you can be successful in spite of things that might seen out of your control.

Shango Los: Aeron Sullivan is founder of Tradiv. You can find out more at tradiv.com. You can find more episodes of the Ganjapreneur podcast in the podcast section at Ganjapreneur.com and in the Apple iTune store. On the Ganjapreneur.com website, you will find the latest cannabis news, product reviews, and cannabis jobs updated daily along with transcriptions of this podcast.

You can also download the ganjapreneur.com app in iTunes and in Google Play. For info on me and where I’ll be speaking, you can go to shangolos.com. Do you have a company that wants to reach our national audience of Cannabis enthusiasts? E-mail grow@ganjapreneur.com to find out how. Today’s show is produced by Michael Roe. I’m your host Shango Los.

End


Perennial Holistic Wellness Center

a word from our sponsors:

advertisement

advertise here

perenniallogoRecently, the Ganjapreneur team was down in Southern California for the Green Flower Media Cannabis Entrepreneurs Summit and we asked around for a “must visit” cannabis dispensary in the area. There were a few mentioned but Perennial Holistic Wellness Center in Studio City was so often repeated that we had to go.

The first thing that you’ll notice, if you are not from LA, is that there is valet parking… for a cannabis dispensary. We learned that because of poor parking in so much of the Los Angeles area, this is becoming more common for upscale dispensaries. For most of the team, however, this was new and novel.

perennial1

The wood paneled check-in area was modern and comfortable. No loud radios or blaring TVs, just a calm and friendly team of hosts to check IDs and welcome us. The shop has been open for ten years and has expanded a few times. We got a kick out of seeing a movie prop from Pineapple Express displayed alongside a few of their “Best Medical Dispensary” awards. We sat down and thumbed a magazine but were almost immediately whisked back to the dispensary.

perennial2

We were caught off guard to find a fully-functioning grow in the hallway. While the setup only produces a small amount of the overall volume that Perennial provides, it was fun to see and gave the whole place a very tropical vibe. We imagine that the grow will be especially fun for folks who may never have seen a cannabis plant in person. It allows the staff to walk patients over to the grow room and use it as a visual aid when explaining some of the finer points of cannabis botany. Also in the hallway is a dedicated clone room providing cannabis starts to patients. It is sealed from the rest of the dispensary to discourage contaminants, but you can clearly identify the strains available during your visit based on their large tags.

perennial5

The selection of cannabis products was very impressive. An array of flowers were available for every ailment or celebration. Lots of colors. We were especially pleased that the terpenes were on point for every jar we opened. We wish that was more common in dispensaries. There was an array of price points as well, so both nerdy connoisseurs and the budget-conscious could find relief. We appreciate Perennial’s emphasis on probiotic growing techniques and were happy to hear that they intentionally foster that in their producer partners.

perennial4

The concentrates were on display with a light behind them for those who shop by color. There were several extraction methods available, including hydrocarbons, CO2 and rosin.

The edibles selection was really exceptional. There were so many kinds of foods to choose from but most important was that the dosages available went from 10mg all the way up to 100mg meaning that both cannabis dabblers and hardcore patients both had something available to them.

One of the things about the SoCal scene we really like is how professional the packaging has become, and Perennial offered well-produced products that also look cool when you show them to your friends.

perennial6

They had quite a bit in the way of discrete medicating including cannabis oil cartridge pens, as you would expect, but also sneaky mechanisms like inhalers that look like they are for asthma totally great stuff for patients who need relief on the go or for attending a sporting event.

perennial8

Everyone at Perennial was smiling and welcoming. We casually quizzed the staff and they handled it all easily. Altogether, it was a very pleasant experience, and we even had a pair of celebrity sightings while there.

We will be back for sure and expect that Perennial’s selection, expertise and kind environment will be a welcome experience for most any cannabis enthusiast.

Perennial Holistic Wellness Center
11705 Ventura Blvd
Studio City, CA 91604
(818) 505-3631
www.perennialholistic.org

End


Head of Illinois Medical Cannabis Program Resigns

a word from our sponsors:

advertisement

advertise here

The second person chosen by Illinois Gov. Bruce Rauner to head the state’s medical cannabis program has resigned, the Associated Press reports. The Bureau of Agriculture’s chief of the pilot medical cannabis program, Jack Campbell, will take over the role.

Joseph Wright held the post for just over a year, and his resignation comes as the governor considers signing legislation that would extend the program another two years.

According to the report, the 32-year-old Wright said it was the right time to pursue other opportunities, possibly with a private sector cannabis company. He earned $53,770 annually in his role with the government.

Wright’s successor ran for Sangamon Sheriff as a Republican in 2014, which he lost in the primary. He retired as a sergeant with the county last January. Campbell began his role with the Ag Department last summer.

Bob Morgan, the first program director, called Campbell’s hiring “good news for patients,” noting that he has been a part of the medical marijuana program since its implementation.

“[He] has a strong reputation for how he has engaged with cultivation centers,” he said in the report.

The extension agreed on by the governor and lawmakers also adds post-traumatic stress disorder and terminal illness to the list of qualifying conditions. Once signed by Gov. Rauner, the program will continue until 2020 – the original legislation allowed for a four-year pilot program.

End


California Legalization Initiative Secures Spot on November Ballot

a word from our sponsors:

advertisement

advertise here

California will decide on legalizing marijuana for recreational use in November, after the Secretary of State’s office confirmed supporters submitted more than enough signatures for a ballot initiative, according to a Reuters report.

“Today marks a fresh start for California, as we prepare to replace the costly, harmful and ineffective system of prohibition with a safe, legal and responsible adult-use marijuana system that gets it right and completely pays for itself,” Jason Kinney, initiative spokesman, said in a statement.

The “Adult Use of Marijuana Act” would allow individuals 21-and-older to possess up to an ounce of cannabis for personal use and allow personal cultivation of up to six plants. Under the proposal, localities would decide whether or not to allow retail operations, which would be taxed. The Bureau of Marijuana Control would be created within the Department of Consumer Affairs to regulate the industry.

The measure needed more than 402,000 signatures and Secretary of State Alex Padilla is expected to certify the signatures today.

Voters defeated a similar measure in 2010 but, according to a May poll by the Public Policy Institute of California, 60 percent of voters in the state support a regulated marijuana industry. This measure has drawn the support of Lt. Gov. Gavin Newsom and billionaire Sean Parker.

End


Washington Medical Cannabis Database May Not Be Ready by July 1

a word from our sponsors:

advertisement

advertise here

Washington medical cannabis patients and providers should be prepared for delays in the roll-out of the state’s new medical regulations.

In particular, the state-managed database of medical cannabis authorizations is not ready yet, according to an email issued yesterday afternoon by the Washington Department of Health. This could spell dire consequences for Washington cannabis patients.

Lawmakers voted last summer to dismantle the state’s 18-year-old medical cannabis industry, and those regulations  — which assimilate the medical industry into the I-502 recreational market — are supposed to take effect this Friday, July 1. Under the new regulations, patients will be required to get medicine from licensed cannabis retail outlets.

Recreational retailers, however, charge significantly more for cannabis products than dispensaries and collectives charged in the medical industry.

Regulators had planned a database that patients would register with to receive patient recognition cards. With such a card, patients would be allowed to:

  • Purchase cannabis products sales-tax free.
  • Purchase up to three times the legal limit for recreational users.
  • Purchase products infused with higher amounts of THC than recreational users.
  • Grow more than four plants at home.
  • Enjoy full protection from arrest, prosecution, and legal penalties associated with their marijuana activities — though patients will still have an affirmative defense.

If the database is indeed delayed, it will inevitably spell trouble for Washington cannabis patients.

According to the Health Department’s email: “Patients and providers can still purchase marijuana from authorized retail stores; however, they can’t take advantage of the benefits until the database is operational.”

“The department is committed to ensuring patient safety, and it will continue to work on having the database ready as soon as possible,” the department said in its release.

Activists are planning a downtown Seattle protest for tomorrow during the afternoon rush hour to bring attention to the plight of Washington’s medical cannabis patients.

 

End


Seattle Protest Planned for June 30 Against Washington’s MMJ Shutdown

a word from our sponsors:

advertisement

advertise here

The NORML Women of Washington are organizing a protest in Seattle this Thursday, June 30, that aims to bring attention to the unfortunate criminalization of Washington’s robust, 18-year-old medical cannabis industry.

Starting Friday, July 1, medical cannabis patients and caregivers who have not assimilated into Washington state’s hyperregulated and exclusive recreational marijuana marketplace will become criminal, as per the Cannabis Patient Protection Act (SB 5052) passed by Washington lawmakers and signed by Gov. Jay Inslee last summer. For months, long-established dispensaries and community caregivers have been closing up shop — or going underground to the “informal” market — in preparation for the dramatic market shift, leaving many patients without adequate access to their medicine.

“While moving to a regulated system is understandably an imperfect journey, this date is significant because it will make people criminals that Washingtonians have voted to protect and have overwhelmingly supported for nearly two decades,” write the protest organizers on the event’s Facebook page. “This is NOT an anti-502 protest. We support the legalization of adult use marijuana and want to send a message to our representatives and regulators that patients and their caregivers need to be protected during this revolutionary process.”

The protest is scheduled for 4:00 p.m. to 7:00 p.m. on Thursday afternoon and protesters will be gathering on sidewalks at the corner of 6th Ave. and Union Street in Downtown Seattle — one of the busiest places in the city, during some of its busiest hours.

End


D.C. Health Department Backs Retail Cannabis System

a word from our sponsors:

advertisement

advertise here

Washington D.C.’s Department of Health is recommending taxing marijuana in the District, similar to regulatory models for alcohol and tobacco, according to a report issued by the department.

Initiative 71, D.C.’s legalization legislation, passed in February 2015 but so far no infrastructure has been set up for sales. District residents can possess, grow and give away for cannabis for recreational use, but there are no retail locations. 

Projections from ArcView Market Research and New Frontier estimate the legalized marijuana market in D.C. could be worth $93.6 million by 2020, DCist reported in March. Two years ago, Dr. Yesim Sayin Taylor, an official for the Office of the D.C. Chief Financial Officer, estimated the market could be worth $130 million a year assuming that 122,000 people would buy three ounces of cannabis a year at $350 an ounce.

In their report, the Health Department recommended using some of the funds gained from a comprehensive retail system to strengthen drug treatment and education programs, monitoring tobacco and alcohol use for cannabis users and non-users, and providing information to expecting mothers about the risks of marijuana use while pregnant and breast-feeding.

Kaitlyn Bocker, a policy analyst with the Drug Policy Alliance, is urging D.C. officials to move forward with the Health Department’s proposals “immediately.”

“As DOH’s recommendation recognizes, a regulatory system will increase public health and safety, allow our policy makers to address much needed reforms, and generate tax revenue to fund treatment and education,” she said in a DCist report.

End


Cannabis branches hanging out to cure after harvest season.

Cannabis Dispensaries Earn More Per Square Foot than Whole Foods

a word from our sponsors:

advertisement

advertise here

The average medical and/or recreational cannabis dispensary in the U.S. earns more money per square foot than the premium grocery store chain Whole Foods, according to the 2016 Marijuana Business Factbook.

Cannabis retailers have the advantage of dispensing a generally small-sized but expensive commodity, meaning that smaller storefronts can more easily generate the revenue per square foot of larger establishments. However, though the cannabis industry continues to enjoy rapid growth, it faces a wide host of problems ranging from archaic political stigmas to overreaching regulatory restrictions. Banking access in particular remains one of the industry’s most problematic issues, and, until that controversy is solved, cannabis retailers — in part because of the industry’s successful reputation — will remain at heightened risks of robbery and theft.

On average, cannabis dispensaries in 2015 earned $974 in annual revenue per square foot, about five percent more than Whole Foods’ $930 per square foot. On a whole, the cannabis industry earned between $3-4 billion in 2015.

Legalized cannabis isn’t completely edging out the premium grocery chain business, however: Costco stores pull in on average $1,032 per square foot, and the cannabis industry’s total revenue still pales in comparison to Whole Foods’ 2015 earnings of $15 billion. But, with medical marijuana legalized in half the U.S. states and recreational legalization votes coming up in nearly a half-dozen others, cannabis will likely be earning tens of billions of dollars in annual revenue within a decade.

In 2015, legal cannabis easily outpaced Girl Scout Cookies and e-cigarette sales.

End


Oregon Rec. Market Nets $60M in First Five Months of 2016

a word from our sponsors:

advertisement

advertise here

Oregon cannabis dispensaries have sold $60 million worth of recreational marijuana from the launch of 2016 through May 30, Eugene’s Register-Guard reports.

Lawmakers instituted the state’s temporary, early-access recreational cannabis marketplace last October. The state’s official recreational market is undergoing an extensive licensing process but should be fully functional by the end of 2016.

During its earliest months, Oregon’s recreational marketplace went untaxed; since January, however, recreational cannabis sales have been subject to a 25 percent excise tax. According to the Oregon Department of Revenue, the state had logged $14.9 million in recreational tax payments as of May 30, though about half of the state’s 319 dispensaries currently participating in the early recreational marketplace had as of last week failed to file their latest quarterly taxes.

“This is a new program, and some dispensaries are still learning about their tax obligations,” said John Galvin, who manages the Department of Revenue’s cannabis tax program. “We want them to be aware of what they need to do before they end up facing penalties for not filing or paying as they’re required,” Galvin said.

After the state’s official recreational marketplace comes online, the statewide excise tax will be lowered to 17 percent and localities will be allowed to vote for an additional 3 percent tax to help municipalities handle the regulatory costs of legal cannabis.

Oregon cannabis sales almost certainly spiked this month when on June 2 concentrates and edible products became available on the temporary recreational market.

End


Mexico’s Cannabis Reform Bill Stalled by Senate

a word from our sponsors:

advertisement

advertise here

Mexico’s senate has postponed discussing a bill to reform marijuana laws in the country until at least September, VICE reports, raising doubts that President Enrique Peña Nieto’s support for the proposal was anything more than good public relations.

“It looks like he never really wanted it,” Lisa Sánchez, drug policy expert and activist, said in the report. “It’s either that, or [the Institutional Revolutionary Party] now considers that Peña is the liability and his opinion is worth nothing from now until the next presidential elections in 2018.”

Peña submitted the legislation – which would have legalized medical marijuana and raised the decriminalized possession threshold – to lawmakers last April. During a speech to the UN General Assembly, he lauded the bill as a “historic step” in reforming the nation’s drug policies. However, Sánchez noted, it was the president’s own party (PRI) that stalled the bill.

In addition to providing medical cannabis and raising possession amounts, the measure would have reclassified possession as a violation of health legislation instead of a federal penal code violation – which, if enacted, would have freed about 13,000 people jailed in Mexico for minor marijuana crimes.

That reclassification was removed by the PRI, along with the possession thresholds, leaving just the medical portion of the bill – which was also changed by the party to favor the pharmaceutical industry.

“The congress will have to discuss it again but I wouldn’t trust our legislators,” Sánchez said.

End


Supreme Court Rejects Appeal to Save Montana MMJ

a word from our sponsors:

advertisement

advertise here

The U.S. Supreme Court has rejected an appeal against a Montana law that limits medical cannabis caregivers from providing to more than three patients, the Associate Press reports.

The rejection means that a controversial ruling made by the Montana Supreme Court in February still stands, and the state’s medical cannabis industry will be effectively snuffed out as of August 31, 2016. The February ruling upholds the state’s three-patient restriction law, a provision that was originally passed in 2011 following a series of federal raids against several of Montana’s large-scale cannabis providers and cultivation facilities.

Activists launched a petition campaign in March to delay the restrictions’ implementation until the end of the 2017 legislative session. The Montana Supreme Court, however, ruled in April that the restrictions would take effect on August 31. This, according to the court, would give cannabis patients and the Montana Health Department more time to handle any fallout associated with such a massive scaling back of the industry.

In turn, activists scrambled to assemble a voter initiative for this November’s voting season. The initiative, I-82, aims to undo the three-patient restriction and adds post-traumatic stress disorder to the state’s list of qualifying conditions for medical cannabis. I-82 would also establish licensing fees to help pay for the program, and would result in specialized provider licenses and annual inspections for Montana’s dispensary facilities.

Montana first legalized medical cannabis in 2004.

End


Smuggle Portland Invites Oregonians to Own a Piece of the Cannabis Industry

a word from our sponsors:

advertisement

advertise here

Oregonians can now easily invest in the legal cannabis movement. Smuggle Portland is raising $250,000 to transform their online store into a flagship location in Portland that sells high-end, cannabis-related accessories designed for women and Baby Boomers.

Community public offerings (CPO) give local businesses an option to avoid national banks and endorse alternative financing mechanisms. This approach is different from donation-based crowdfunding, like Kickstarter and Indiegogo. CPO investors get their money back plus interest. They also boost Oregon’s makers community whose sophisticated and sustainable products are sold by Smuggle Portland.

Smuggle’s co-founder, Renee Spears, said, “Baby Boomers and women are fast growing segments in cannabis. They don’t want to visit a headshop with black lights and blacked-out windows. We’re offering them a welcoming and elegant experience, both at our retail location and online. We want to help them stay healthy and conscious with products that epitomize the Pacific Northwest, cannabis lifestyle.”

Based on sales recorded for the Seattle Metro area, Portland is likely to sell over $200 million in cannabis alone in 2016. The associated products market is valued at twice that amount. This estimates the local ancillary market to be worth $400 million this year. Smuggle co-founder, Stephen Cahill, said, “We’re eager to meet our investors, share our business model, and demonstrate how we’re making decisions in this rapidly changing culture. I see our investors as thought leaders who want to align their money with their values.”

  • Any Oregon resident can invest until May 2017 at http://www.invest-smuggleportland.com/
  • Oregon is one of 10 states to have this unique, intra-state offering.
  • Women are the fastest growing demographic in the cannabis industry, and are responsible for
  • 70% of purchase decisions in America.
  • Baby Boomers are expected to account for 25% of market growth in cannabis over the next five years (Upstart Business Journal).
smuggle2
Smuggle Portland’s founders, Renee Spears and Stephen Cahill.

Smuggle Portland is co-founded by Renee Spears, owner of Rose City Mortgage and winner of numerous business awards in Oregon. Her co-founder is Stephen Cahill, a former MBA professor in business innovation at Pinchot University. Their staff includes a talented assortment of retail experts, product designers, videographers, system developers, and cannabis connoisseurs. They come from Nike, Banana Republic, and Liz Claiborne.

End


Supreme Court Rules Forced DUI Blood Tests Unconstitutional

a word from our sponsors:

advertisement

advertise here

Civil liberty advocates celebrated a major victory on Thursday after the U.S. Supreme Court ruled it unconstitutional for law enforcement officers to perform forced blood tests without a warrant on individuals suspected of a DUI, The Free Thought Project reports.

In Washington, this decision should lead to the overturning of that state’s DUI laws regarding cannabis because, currently, the only official method of testing a driver for THC-impairment is via blood test.

After the 2012 passing of Washington’s I-502, which legalized recreational cannabis, the state also established new DUI laws: in post-legalization Washington, drivers are not allowed to have more than 5 nanograms of active THC per milliliter of blood. For regular cannabis consumers, that is an absurdly low limit that essentially negates a regular consumer’s ability to legally drive themselves anywhere.

However, with forced blood tests now declared unconstitutional on a national level, Washington officials must seek a new way of checking drivers for THC impairment.

The Supreme Court decision ultimately ruled that breathalyzers do not require warrants but blood tests do because they are significantly more invasive: they both pierce the skin and leave behind a biological sample in the government’s possession.

End


Are Your Cannabis Customers Getting the Message?

a word from our sponsors:

advertisement

advertise here

Call it copy, text, messaging, content or whatever you like, but many cannabis business owners simply do not give the messages they send to customers the effort that is required in an age of customer control. Messaging on packaging, signs, ads, websites, product descriptions, and sales copy almost universally falls short — messages are limited, confusing, and in some cases just outright horrific.

Nobody ignores this part of their business on purpose. Customers just don’t behave like they used to. Smartphones and mobile devices have rendered tried and true sales and marketing methods that have worked for decades irrelevant. This dramatic shift has left business owners scratching their heads.

While the customer’s ultimate experience with your business (or product) is the foundation of growing your business, the messaging and copy that surrounds it can make a game-changing difference in how fast and how broad of an appeal your product has.

The idea that ‘one’ message will move everyone in your prospective customer base to buy what you sell is a very bad idea.

The motivations and needs that drive the purchase of any one product can vary wildly.

How We Make Decisions

Typically, we all make buying decision along two axes.

  1. Quick vs. Deliberate –or
  2. Emotional vs. Logical

Each quadrant represents a major buying mode that you can start taking into account when crafting messages of any kind.

4 Major Buying Mods

Look at the buying modes applied lightly to buying a strain cannabis flower.

  1. The Competitive buyer wants superior weed. Depending on their need, high THC or CBD percentages, or even flavor is their priority. Exclusivity is a plus too.
  2. The Humanistic buyer is about people and relationships.  They would like to know about the grower, would like to know about the seller, and especially wants to know if people like her have bought this strain. Is there a story behind the strain?
  3. The Methodical buyer wants value. More for less, sales, and added value excite the methodical buyer. Needs detailed data about each strain.
  4. The Spontaneous buyer wants to have fun. Novelty, a fun budtender, and description of the experience will get them excited.

Now look at how the four primary buying ‘modes’ come into play when buying a glass water pipe.

  1. The Competitive buyer wants a superior piece, one he can show off and is better than all or most of their friends. Will be interested in big brand names or exclusive artists/designs.
  2. The Humanistic buyer wants to know the glass blower or about the manufacturer and what they stand for.
  3. The Methodical buyer wants value. They will buy the most glass for the least amount of money.
  4. The Spontaneous buyer wants convenience. Make it easy and fun and this buyer will be hooked. Novelty design, unique features or anything that adds fun or dimension to the smoking experience.

What This Means for You

You’ll discover a whole new world of sales and growth opportunity when you understand of how to communicate to prospects in their buying modes. Not just for messaging that sells better but for crafting compelling customer experiences, even products.

Keep in mind this isn’t a comprehensive description of each buying mode’s needs and motivations, it is just a start. And we have yet to take into account how each behaves at each buying stage or detail their different processes for making a buying decision.

Wouldn’t all this be helpful to know when writing copy for a new product, designing packaging, writing strain descriptions, etc.?

You might recognize your own primary buying style or some of your customers here.  But the point is simple. If you don’t start communicating with your customers in a way they prefer to be communicated with and/or sell to them in a manner they prefer, your messaging will miss the mark. Period.

Your prospective customers have too many choices and too little time to stick around waiting for you to get it right, especially if your competitors are speaking their buying language already. It’s no longer enough to just communicate. You must speak directly to your customers felt needs. And from customer to customer—individual felt needs can be as different as oil and water.

Are you accounting for those differences in your messaging?

Now would be a good time to start.

End